Tag: Drugs

Search News
Categories
Archives
Immune therapy reduces risk of recurrence in aggressive breast cancer

27th February 2020

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Barts Cancer Institute, Queen Mary University of London.

Read more

Tackling resistance in skin cancer

13th January 2020

Researchers have found that melanoma cells fight anti-cancer drugs by changing their internal skeleton (cytoskeleton) – opening up a new therapeutic route for combating skin and other cancers that develop resistance to treatment.

Read more

IBIS-II – new results from international breast cancer study

12th December 2019

The Queen Mary University of London professor leading an international breast cancer study says anastrozole – rather than tamoxifen – should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.

Read more

KEYNOTE-522: Immune therapy for breast cancer

30th September 2019

Results of an interim analysis from the KEYNOTE-522 trial have shown a treatment combination of immunotherapy plus chemotherapy to improve response rates in patients with early triple-negative breast cancer. Prof Peter Schmid presented the results at the ESMO Congress 2019 in Barcelona, Spain.

Read more

Antibody therapy in pancreatic cancer

31st July 2019

Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion. Called avb6, the protein is present on the surface of more than 80 per cent of pancreatic ductal adenocarcinoma – the most common form of pancreatic cancer – and is vital to increase the successful growth and spread of the tumour cells.

Read more

New research funded by PCRF

19th July 2019

The Pancreatic Cancer Research Fund is supporting two new research projects at the Barts Cancer Institute, Queen Mary University of London. The projects, led by Professor Hemant Kocher and Dr Gunnel Halldén, will aim to identify ways to enhance the efficacy of treatments for pancreatic cancer, to ultimately help those affected by this devastating disease.

Read more

Search News
Categories
Archives
Upcoming Events
  1. The London Pancreas Workshop 2020

    May 1 @ 9:30 am - 4:30 pm
  2. 2020 Circulating Cancer Biomarker Symposium

    May 4 @ 9:00 am - 5:30 pm
© 2013 ~ 2020 Cancer Research UK Barts Centre